Rising Technological Advancements in Sepsis Diagnosis to Drive Middle East & Africa Sepsis Diagnostics Market Growth During 2021–2028
Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the process of sepsis diagnosis, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The adoption of molecular diagnostic technology is increasing due to its several advantages, such as high sensitivity, accuracy, and less turnaround time than other technologies. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. Thus, the rising use of technology such as molecular diagnostics in sepsis diagnosis is a crucial trend followed by emerging key players operating in the Middle East & Africa sepsis diagnostics market.
Middle East & Africa Sepsis Diagnostics Market Overview
The UAE, Saudi Arabia, and South Africa are three major countries in the Middle East & South Africa. The Middle East & Africa sepsis diagnostics market growth is attributed to factors such as growing healthcare expenditure, rising incidence of sepsis diseases, increasing awareness, and the development of innovative diagnostic products by the market players.
Middle East & Africa Sepsis Diagnostics Market Segmentation
The Middle East & Africa sepsis diagnostics market is segmented into product, method, test type, pathogen, end user, and country.
Based on product, the Middle East & Africa sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the Middle East & Africa sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the Middle East & Africa sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the Middle East & Africa sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the Middle East & Africa sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the Middle East & Africa sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the Middle East & Africa sepsis diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the Middle East & Africa sepsis diagnostics market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 19.20 Million |
| Market Size by 2028 | US$ 33.35 Million |
| CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East & Africa Sepsis Diagnostics Market is valued at US$ 19.20 Million in 2021, it is projected to reach US$ 33.35 Million by 2028.
As per our report Middle East & Africa Sepsis Diagnostics Market, the market size is valued at US$ 19.20 Million in 2021, projecting it to reach US$ 33.35 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
The Middle East & Africa Sepsis Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Sepsis Diagnostics Market report:
The Middle East & Africa Sepsis Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Sepsis Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Sepsis Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Sepsis Diagnostics Market
